Détails du rapport Vaer
Région : Outside US
- Patient décédé?
- Renseignements sur les vaccins
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
- Date de réception du rapport
- Date à laquelle le formulaire est complèté
- Date de vaccination
- Date d’apparition
- Nombre de jours (date d’apparition – date de vaccination)
- Description de l’événement indésirable
phlegm; flu-like symptoms; very raw nasal cavity; cold symptoms; sore throat; sore eyes; earache; muscle ache; primary immunisation: non-pfizer vaccine; booster: comirnaty; primary immunisation: non-pfizer vaccine; booster: comirnaty; sneezing; headache; thick mucus in throat; all over body ache; this is a spontaneous report from a contactable consumer, the patient. this is a report received from the regulatory agency (ra). regulatory authority report number is gb-mhra-webcovid-202202191747011040-xsaxh with safety report unique identifier gb-mhra-adr 26625912. a 45-year-old male patient received third (booster) dose of bnt162b2 (comirnaty; lot number: unknown) via an unspecified route of administration on 13feb2022 as a single dose for covid-19 immunisation. medical history was not reported. it was reported that the patient was not taking medicines. on 26jan2022, the patient underwent covid-19 virus test and the result was negative. the patient did not have symptoms associated with covid-19 and was not enrolled in clinical trial. concomitant medications were not reported. the patient previously received first and second dose of covid-19 vaccine (manufacturer unknown); both on unknown dates, for covid-19 immunisation. on 13feb2022 the patient experienced primary immunisation: non-pfizer vaccine; booster: comirnaty.on 14feb2022, 1 day after vaccination, the patient experienced cold symptoms, sore throat, sore eyes, earache, muscle ache; on 15feb2022, 2 days after vaccination, the patient experienced phlegm; on an unknown date in feb2022, the patient experienced sneezing, headache; all the events were reported as serious for being medically significant. the clinical course reported as follows: on 14feb2022, within one day the patient experienced flu-like symptoms, these started with sore eyes, sore throat and sore ears with very raw nasal cavity and headache. these lasted about 2 days and have now left sneezing, thick mucus in throat (medically significant ) and on an unknown date in feb2022, the patient experienced all over body ache. the clinical outcome of the events sore eyes was recovered on 15feb2022 after the duration of 1 day, while that of sore throat, earache was recovered on 16feb2022 after the duration of 2 days. the clinical outcome of the events sneezing, cold symptoms, headache and very raw nasal cavity was recovered on an unknown date in feb2022. the clinical outcome of the events muscle ache and phlegm was not recovered, while that of the events all over body ache, flu-like symptoms, thick mucus in throat, primary immunisation: non-pfizer vaccine; booster: comirnaty were unknown. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected
- Données de laboratoire
test date: 20220126; test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
- Liste des symptômes
headache pain productive cough ear pain eye pain myalgia influenza like illness interchange of vaccine products nasal discomfort oropharyngeal pain nasopharyngitis sars-cov-2 test sneezing off label use increased viscosity of bronchial secretion
- Patient décédé?
- Date de décès
- Anomalie congénitale
- Vaccin administré par :
- Vaccin acheté par :
- Visite d’un patient à l’urgence?
- Patient hospitalisé?
- Séjour à l’hôpital
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Maladie actuelle